Table 2.

Baseline prevalence of primary and secondary mental health outcomes in people newly diagnosed with vitiligo and matched controls

	Matched controls,	Vitiligo cases,
	n (%)	n (%)	P-value
Total number of patients	28 880	7224	−
Primary mental health outcomes
Recurrent depressive disorder	4305 (14.9)	1093 (15.1)	0.647
Depressive episodes	4007 (13.9)	1018 (14.1)	0.647
Anxiety disorder	2031 (7.0)	569 (7.9)	0.014*
Secondary mental health outcomesa
Adjustment disorder	232 (0.8)	62 (0.9)	0.696
Substance misuse	900 (3.1)	195 (2.7)	0.070
Self-harm	215 (0.7)	46 (0.6)	0.374
Parasuicide	236 (0.8)	61 (0.8)	0.876

Data are number (percent) of the total number of patients with the condition in each subgroup.

^a.Social phobia prevalence is not reported because fewer than five events were recorded in vitiligo cases.

^*P < 0.05.